Navigation Links
NCPA Commends Senate Aging Committee for Launching CVS Caremark Investigation to Examine Alleged Harm to Seniors, Medicare
Date:9/29/2010

ALEXANDRIA, Va., Sept. 29 /PRNewswire-USNewswire/ -- The National Community Pharmacists Association (NCPA) expressed strong support for an investigation into CVS Caremark launched by the U.S. Senate Special Committee on Aging reported earlier today on the blog Pharmalot.

(Logo: http://photos.prnewswire.com/prnh/20100106/DC33253LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100106/DC33253LOGO)

In response, NCPA President Joseph H. Harmison, PD and Arlington, Texas pharmacy owner, issued the following statement:

"Complaints continue to increase from patients and community pharmacists alleging CVS Caremark of engaging in anti-consumer, anti-competitive behavior. We commend Chairman Herb Kohl (D-Wisc.) for doing the right thing on behalf of patients and pharmacists in Wisconsin and across the nation.  Seniors are both the most in need of pharmacy services and the patients arguably most vulnerable to the misleading and deceptive tactics of which CVS Caremark is accused.

"CVS Caremark's strong-armed efforts to gain market share appear to be compromising patient care while inflating costs for seniors, the Medicare program and taxpayers. For example, retirees Max and Jan Hauser discovered that, under their Medicare drug plan administered by CVS Caremark, the cholesterol drug Simvastatin that cost them nothing at a local independent pharmacy cost them $165.99 at CVS for a three-month supply. As reported by WCNC-TV they were also charged more by CVS for ulcer drugs and blood pressure medicine. The combined higher costs charged by CVS pushed the fixed-income couple into their plan's coverage gap (or 'donut hole') sooner, significantly increasing their out-of-pocket drug costs.

"In addition, seniors who prefer the face to face service and counseling of their independent community pharmacist are forced by CVS Caremark to switch to its mail order or to travel greater distances to the nearest CVS location. In the newly released J.D. Power and Associates 2010 National Pharmacy Study, patients rated CVS Caremark retail and mail order pharmacies significantly lower than its rivals in customer satisfaction.

"The Senate committee joins a long and growing list of investigations into anti-consumer, anti-competitive allegations against CVS Caremark. The Federal Trade Commission is in the midst of a non-public investigation involving both its Bureaus of Competition and Consumer Protection and with the support of dozens of members of Congress. In addition, approximately 24 states are pursuing their own investigations. Community pharmacists and their patients are looking for comprehensive relief from the FTC and other regulators to stop any anti-competitive and deceptive practices by CVS Caremark."

The National Community Pharmacists Association (NCPA®) represents America's community pharmacists, including the owners of more than 22,700 independent community pharmacies, pharmacy franchises, and chains. Together they represent an $88 billion health-care marketplace, employ over 65,000 pharmacists, and dispense over 40% of all retail prescriptions. To learn more go to www.ncpanet.org or read NCPA's blog, The Dose, at http://ncpanet.wordpress.com.


'/>"/>
SOURCE National Community Pharmacists Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing
2. CHMP Recommends Expanded Use of Angiox(R) (Bivalirudin) in Europe for Patients With Acute Coronary Syndromes
3. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
4. FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
5. Lung Cancer Alliance Commends NCCN on Screening Guidelines
6. FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
7. Task Force Recommends Screening for Hearing Loss in All Newborns
8. CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients
9. Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout
10. CHMP Recommends Approval in the European Union (EU) for New Options for Patients With Certain Primary Brain Tumors
11. Independent Data Monitoring Committee Recommends Resuming Enrollment of Non-Squamous NSCLC Patients in the Motesanib MONET1 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... 2017 Sherpa Clinical Packaging ( www.sherpaclinical.com ... is pleased to announce the appointment of Kevin Rosenthal as ... Sherpa team to lead Sherpa,s Operations group and ... excellence. Kevin is not new to ... He has extensive experience working for leading pharma ...
(Date:1/24/2017)... YORK , January 24, 2017 ... the fastest growing industries in the United States ... medicinal use in 2016. In addition, Proposition 64, the California ... for and 42.87% against on November 8, 2016. This outcome ... allowed to use and to grow a certain amount of ...
(Date:1/24/2017)... 24, 2017   Keneric Healthcare , a ... effective patient care products, today announced their partnership ... the reach of both companies by leveraging their ... Angelini Pharma Inc . ... include Keneric Healthcare,s RTD™ Wound Dressing (antibacterial/antifungal).  RTD™ ...
Breaking Medicine Technology:
(Date:1/24/2017)... Houston, TEXAS (PRWEB) , ... January 24, 2017 ... ... firm and solution provider of enterprise software products, today announced a strategic partnership ... enable Element Blue users to access and analyze their Fusion platform for building ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... was recently accepted as a Registered Trademark by the United States Patent and ... a similar name which could confuse consumers into thinking that other products are ...
(Date:1/24/2017)... ... January 24, 2017 , ... Twelve startups have been ... 2017 Cupid's Cup Entrepreneurship Competition. Chaired by Under Armour Founder and CEO Kevin ... will showcase their businesses on February 6, 2017, at Under Armour’s global headquarters ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... it has officially formed a distribution partnership with Byers Scientific & Manufacturing ... management industry. , Through the agreement, OMI Industries formulated a special version of ...
(Date:1/24/2017)... , ... January 24, 2017 , ... Center for ... century leadership, has named Hector M. Chavez, Manager, Employee & Labor Relations at ... - as its Hispanic Leader of the Month. City of Hope is committed to ...
Breaking Medicine News(10 mins):